Product Information
LABETALOL HCL 300 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.2086 per EA under NDC 68382080001. Its NADAC has been published 425 times since May 9, 2018.
Strength
300 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382080001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LABETALOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207743On Market Since
12/5/2017
Pharmacological Classes
Price Statistics
The NADAC for LABETALOL HCL 300 MG TABLET has been published 425 times since May 9, 2018, and over the history we have for it it has declined 40.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2086 per EA |
|---|---|
| All-time high | $0.3525 (Jun 13, 2018) |
| All-time low | $0.1776 (Nov 20, 2024) |
| 52-week high | $0.2117 |
| 52-week low | $0.1998 |
| Median price | $0.2218 |
| Average price | $0.2423 |
| Largest weekly change | +21.9% (Feb 17, 2021) |
| Weeks tracked | 425 |
| Tracking since | May 9, 2018 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LABETALOL HCL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 300 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.2086 per EA (NDC 68382080001), effective Jun 24, 2026.
How has the price of LABETALOL HCL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for LABETALOL HCL 300 MG TABLET has declined 40.1%. It has been tracked across 425 weekly CMS publications since May 9, 2018.
What are the highest and lowest recorded NADAC prices for LABETALOL HCL 300 MG TABLET?
Since May 9, 2018, the NADAC for LABETALOL HCL 300 MG TABLET has ranged from a low of $0.1776 (Nov 20, 2024) to a high of $0.3525 (Jun 13, 2018), with a median of $0.2218 per EA.
Are there cheaper alternatives to LABETALOL HCL 300 MG TABLET?
Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LABETALOL HCL 300 MG TABLET, is $0.2041 per EA — about 2% below LABETALOL HCL 300 MG TABLET.
Who manufactures LABETALOL HCL 300 MG TABLET?
LABETALOL HCL 300 MG TABLET (NDC 68382080001) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification